HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prostaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysis.

AbstractPURPOSE:
To estimate the intraocular pressure (IOP)-lowering effect of prostaglandin analogs (PGAs) administered in combination with β-blockers.
METHODS:
We searched the Medline and Embase databases for randomized trials comparing topical therapies with PGAs and timolol administered as monotherapy (Mt), or in fixed (FC) or unfixed combinations (UC) to patients with glaucoma or ocular hypertension. The efficacy endpoint was the mean difference (MeD) in the reduction in IOP from baseline; the tolerability endpoint was the incidence of hyperemia.
RESULTS:
The 18 eligible trials involved 23 comparisons of FC versus Mt, and 5 of FC versus UC. The FCs were less efficacious than UCs (MeD: 0.69, 95% CI: 0.29 to 1.08). In comparison with timolol Mt, the latanoprost/timolol FC led to a greater IOP reduction (MeD: -2.74, 95% CI: -3.24 to -2.23) than the bimatoprost/timolol FC (MeD: -1.49, 95% CI: -1.86 to -1.12) or the travoprost/timolol FC (MeD: -1.93, 95%CI: -2.98 to -0.88). The FCs led to a lower hyperemia risk than UCs [relative risk (RR): 0.70, 95% CI: 0.43 to 1.14] and PGA Mt (RR: 0.61, 95% CI: 0.53 to 0.70).
CONCLUSIONS:
FCs are more efficacious than their individual components, but less efficacious than their respective UCs. FCs lead to a lower hyperemia risk than UCs and their respective PGA Mts.
AuthorsLuciano Quaranta, Elena Biagioli, Ivano Riva, Eliana Rulli, Davide Poli, Andreas Katsanos, Irene Floriani
JournalJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (J Ocul Pharmacol Ther) Vol. 29 Issue 4 Pg. 382-9 (May 2013) ISSN: 1557-7732 [Electronic] United States
PMID23231442 (Publication Type: Comparative Study, Journal Article, Meta-Analysis, Review, Systematic Review)
Chemical References
  • Antihypertensive Agents
  • Drug Combinations
  • Prostaglandins
  • Timolol
Topics
  • Antihypertensive Agents (administration & dosage, adverse effects, therapeutic use)
  • Drug Combinations
  • Drug Therapy, Combination
  • Glaucoma, Open-Angle (drug therapy, physiopathology)
  • Humans
  • Hyperemia (chemically induced, epidemiology)
  • Intraocular Pressure (drug effects)
  • Ocular Hypertension (drug therapy)
  • Prostaglandins (administration & dosage, adverse effects, therapeutic use)
  • Timolol (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: